Clinical studies of loracarbef

CHEMOTHERAPY

Volumn 41, Issue , 1993, Pages 184-187

  Shiba, Kohya ^a   Yoshida, Masaki ^a   Hori, Seiji ^a   Shimada, Jingoro ^a   Saito, Atsushi ^a   Sakai, Osamu ^a   Matsumoto, Fumio ^b   Imai, Takeo ^b   Hojo, Toshio ^b   Takahashi, Takayuki ^b   Morita, Masayuki ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Kanagawa Prefecture Midwives and Nurses Training School Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LORACARBEF;

ARTICLE; BRONCHITIS; CLINICAL ARTICLE; CYSTITIS; DRUG BLOOD LEVEL; DRUG EFFICACY; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PNEUMONIA;

EID: 0027458049     PISSN: 00093165     EISSN: None     Source Type: Journal    
DOI: 10.11250/chemotherapy1953.41.Supplement3_184     Document Type: Article

References (4)

1. Matsukuma I, Yoshiiye S, Mochida K, Hashimoto Y, Sato K, Okachi R and Hirata T: Synthesis and biological evaluation of 3- chloro- 1- carbacephem compounds. Chem Pharm Bull 37: 1239–1244, 1989
2. Sato K, Okachi R, Matsukuma I, Mochida K and Hirata T: In vitro and in vivo antibacterial activity of KT3777, a new orally active carbacephem. J Antibiotics 42: 1844~1853, 1989
3. Cao C, Chin NX and Neu HC: In-vitro activity and β-lactamase stability of LY163892. J Antimicrob Chemther 22: 155~165, 1988
4. 40, KT3777, 1992